Edit

Kross Partner

https://www.oaklins.com/fr/en/index.html
Last activity: 18.03.2025
Active
Categories: FinTech
Fondé en 2016, Kross Partner est un cabinet de conseil en M&A spécialisé dans l'industrie de la nutrition et du bien-être. En trois ans, Kross Partner a réalisé plus d'une quinzaine d'opérations sell-side, buy-side ou de levée de fonds dans les industries du complément alimentaire, de la cosmétique, de la nutrition-santé ou du dispositif médical.

En juillet 2019, les équipes de Kross Partner ont rejoint le réseau international de banques d'affaires Oaklins, pour y renforcer les verticales nutrition et bien-être.

Créée il y a presque 15 ans par Thibaut de Monclin et Eric Felix-Faure, l’équipe d’Oaklins en France compte aujourd’hui 32 professionnels dont 8 Partners à Paris, Lyon et Toulouse.
En réalisant plus de 400 transactions depuis sa création, Oaklins France est devenue une banque d’affaires indépendante de référence en France sur le midmarket.
Aujourd’hui, l’équipe hexagonale, experte en conseils stratégiques et financiers, bénéficie du relais de 800 professionnels Oaklins à travers le monde (60 bureaux dans 40 pays sur 5 continents), regroupés au sein de 15 divisions sectorielles dédiées, permettant de valoriser leurs expertises « métier » cross-border.
Ensemble, au cours des cinq dernières années, les équipes d’Oaklins ont réalisé quelque 1.500 transactions dans le monde dont plus de la moitié en crossborder.
Website visits
26.5K /mo.
Mentions
22
Employees: 11-50
Founded date: 2016

Mentions in press and media 22

DateTitleDescription
18.03.2025Nightingale Health's Leap into the U.S. Market: A New Era for Health InnovationNightingale Health is making waves. The Finnish health tech company is set to launch its American Depositary Receipt (ADR) program in the United States. This move opens the door for U.S. investors to engage with a company that is redefining...
18.03.2025Nightingale Health Takes Flight: Transitioning to Nasdaq Helsinki's Main MarketNightingale Health Plc is on the verge of a significant leap. The Finnish Financial Supervisory Authority has given the green light for the company’s Finnish prospectus. This approval marks a pivotal moment as Nightingale Health prepares to...
18.03.2025Nightingale Health Plc’s listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025Nightingale Health Plc’s listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025 Tue, Mar 18, 2025 10:30 CET Report this content Nightingale Health Plc St...
17.03.2025Nightingale Health establishes ADR program in the US – trading in Company’s B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US...Nightingale Health establishes ADR program in the US – trading in Company’s B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US Mon, Mar 17, 2025 12:55 CET Report this ...
17.03.2025The Finnish Financial Supervisory Authority has approved Nightingale Health Plc’s Finnish prospectusThe Finnish Financial Supervisory Authority has approved Nightingale Health Plc’s Finnish prospectus Mon, Mar 17, 2025 15:15 CET Report this content Nightingale Health Plc Stock exchange release 17 March 2025 at 4:15 p.m. EET The Finnish Fi...
12.03.2025Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq HelsinkiNightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki Wed, Mar 12, 2025 13:30 CET Report this content Nightingale Health Plc Stock exchange release 12 March 2025 at 2:30 p.m. (EET) Nightin...
28.11.2024Nightingale Health and White Pearl Technology: A New Dawn for Nordic Companies in the U.S. MarketIn the world of business, change is the only constant. Two Nordic companies, Nightingale Health and White Pearl Technology Group, are making waves as they explore new horizons in the U.S. market. Their recent announcements signal a shift in...
28.11.2024Navigating the Waters of Change: Redsense Medical and Nightingale Health's Strategic MovesIn the ever-evolving landscape of healthcare technology, two companies are making waves: Redsense Medical and Nightingale Health. Both are charting new courses, adapting to market demands, and seeking growth opportunities. Their recent anno...
27.11.2024Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S.Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S. Wed, Nov 27, 2024 13:20 CET Report this conten...
08.11.2024Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health PlcResolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc Fri, Nov 08, 2024 16:00 CET Report this content Nightingale Health Plc Company release 8 November 2024 at 5:00 p.m. (EET)...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In